2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

被引：1342

作者：

Hughes, WT

Armstrong, D

Bodey, GP

Bow, EJ

Brown, AE

Calandra, T

Feld, R

Pizzo, PA

Rolston, KVI

Shenep, JL

Young, LS

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA

[6] Kuzell Inst Arthrit, San Francisco, CA USA

[7] Univ Manitoba, Winnipeg, MB, Canada

[8] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[9] CHU Vaudois, CH-1011 Lausanne, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 34卷 / 06期

关键词：

D O I：

10.1086/339215

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guidelines Panel, updates guidelines established a decade ago by the Infectious Disease Society of America for the use of antimicrobial agents to treat neutropenic patients with unexplained fever [1].

引用

收藏

页码：730 / 751

页数：22

相关论文

共 195 条

[91] HIGH-DOSE INTRAVENOUS CIPROFLOXACIN IN FEBRILE NEUTROPENIC PATIENTS [J].

JOHNSON, PRE ;

YIN, JAL ;

TOOTH, JA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 :101-107

[92] A RANDOMIZED TRIAL OF HIGH-DOSE CIPROFLOXACIN VERSUS AZLOCILLIN AND NETILMICIN IN THE EMPIRICAL THERAPY OF FEBRILE NEUTROPENIC PATIENTS [J].

JOHNSON, PRE ;

YIN, JAL ;

TOOTH, JA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (02) :203-214

[93] RISK-FACTORS FOR RECURRENT FEVER AFTER THE DISCONTINUATION OF EMPIRIC ANTIBIOTIC-THERAPY FOR FEVER AND NEUTROPENIA IN PEDIATRIC-PATIENTS WITH A MALIGNANCY OR HEMATOLOGIC CONDITION [J].

JONES, GR ;

KONSLER, GK ;

DUNAWAY, RP ;

GOLD, SH ;

COOPER, HA ;

WELLS, RJ .

JOURNAL OF PEDIATRICS, 1994, 124 (05) :703-708

[94] CAN ANTIBACTERIAL THERAPY BE DISCONTINUED IN PERSISTENTLY FEBRILE GRANULOCYTOPENIC CANCER-PATIENTS [J].

JOSHI, JH ;

SCHIMPFF, SC ;

TENNEY, JH ;

NEWMAN, KA ;

DEJONGH, CA .

AMERICAN JOURNAL OF MEDICINE, 1984, 76 (03) :450-457

[95]

KELSEY SM, 1992, J CHEMOTHERAPY, V4, P107

[96] OFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PREVENTION OF INFECTION IN PATIENTS WITH ACUTE-LEUKEMIA AND GRANULOCYTOPENIA [J].

KERN, W ;

KURRLE, E .

INFECTION, 1991, 19 (02) :73-80

[97] EMERGENCE OF FLUOROQUINOLONE-RESISTANT ESCHERICHIA-COLI AT A CANCER CENTER [J].

KERN, WV ;

ANDRIOF, E ;

OETHINGER, M ;

KERN, P ;

HACKER, J ;

MARRE, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :681-687

[98] Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: Targeting empirical monotherapy versus combination therapy [J].

Kern, WV ;

Heiss, M ;

Steinbach, G .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) :832-835

[99] Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy [J].

Kern, WV ;

Cometta, A ;

de Rock, R ;

Langenaeken, J ;

Paesmans, M ;

Gaya, H .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :312-318

[100] Low-risk prediction rule for pediatric oncology patients presenting with fever and neutropenia [J].

Klaassen, RJ ;

Goodman, TR ;

Pham, B ;

Doyle, JJ .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) :1012-1019

← 5 6 7 8 9 10 11 12 13 14 →